Home/Filings/4/A/0001104659-23-109616
4/A//SEC Filing

Basho Chandan 4/A

Accession 0001104659-23-109616

CIK 0001083446other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:16 PM ET

Size

11.6 KB

Accession

0001104659-23-109616

Insider Transaction Report

Form 4/AAmended
Period: 2023-05-16
Basho Chandan
COO and CFO
Transactions
  • Disposition to Issuer

    Common Stock

    2023-05-1648,08626,359 total
  • Award

    Common Stock

    2023-05-16+60,80896,288 total
  • Award

    Common Stock

    2023-05-16+9,12135,480 total
  • Award

    Common Stock

    2023-05-16+60,803157,091 total
Footnotes (6)
  • [F1]Represents cancellation of previously-granted performance-based restricted stock award. The original Form 4 filed on May 25, 2023 inadvertently omitted this cancellation. Total holdings in column 5 have been adjusted accordingly, including for previously-reported tax withholdings.
  • [F2]Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 16, 2024.
  • [F3]Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in four equal (as nearly as possible) annual installments, beginning on May 16, 2024.
  • [F4]Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest upon achievement of certain pre-established performance goals.
  • [F5]These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023.
  • [F6]Includes 152,372 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals.

Issuer

Apollo Medical Holdings, Inc.

CIK 0001083446

Entity typeother

Related Parties

1
  • filerCIK 0001929126

Filing Metadata

Form type
4/A
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:16 PM ET
Size
11.6 KB